About

Resources for Patients

Patients and physicians who are not satisfied with current type 2 diabetes treatment regimens should ask about the EndoBarrier. The EndoBarrier is a new, non-surgical device that may enable patients to regain control of type 2 diabetes and achieve weight loss with one treatment. The EndoBarrier is commercially available in select regions in Europe, South America and Australia. The EndoBarrier is not approved for sale in the United States and is considered investigational. There are multidisciplinary treatment centers that now offer the EndoBarrier as part of a complete program designed to help meet a patient's individual health goals.

For more information regarding type 2 diabetes and obesity, and additional patient support resources, please visit the EndoBarrier website for a list of advocacy groups.